Could the potential benefits of cholinesterase inhibitors in Alzheimer's disease be reduced after adjusting for coexisting diseases and multiple medications?
Cheng
Huai Yong
HY
D000544:Alzheimer Disease / Q000150:complications / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003071:Cognition / Q000187:drug effects; D004194:Disease; D004347:Drug Interactions; D006801:Humans; D019338:Polypharmacy
D002800:Cholinesterase Inhibitors